BlackRock, Inc. 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 5,976,266 7.500% | 556,241 (+10.26%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 5,420,025 8.000% | 1,622,456 (+42.72%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 3,797,569 6.500% | 387,711 (+11.37%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 3,409,858 6.000% | 3,409,858 (New Position) | Filing |